Regeneron's obesity drug shows Zepbound-like efficacy in phase 3
Fuente:
FierceBiotech
Regeneron’s Chinese partner reported Zepbound-like efficacy in a phase 3 trial, de-risking one part of the Big Biotech’s differentiated play for the obesity market.